Literature DB >> 9924213

T cell derived cytokines in psoriatic arthritis synovial fluids.

G Partsch1, E Wagner, B F Leeb, H Bröll, A Dunky, J S Smolen.   

Abstract

OBJECTIVE: The aim of this study was to investigate the concentrations of T cell derived cytokines in the synovial fluids (SFs) of patients with psoriatic arthritis (PsA) in comparison with rheumatoid arthritis (RA) and osteoarthritis (OA).
METHODS: Th1 type cytokines (interleukin 2 (IL2), tumour necrosis factor beta (TNF beta), and interferon gamma (INF gamma) and Th2 type cytokines (IL4, IL10) were measured by means of enzyme linked immunosorbent assays.
RESULTS: IL2 was usually not detectable in any of the disease groups. TNF beta was found in 3 of 31 PsA SFs (mean (SEM) 11.1 (2.3) pg/ml) and in a significantly lower concentration than in 20 of the 40 RA SFs (42.2 (15.6) pg/ml; p < 0.002). INF gamma was measurable in 2 of 10 PsA and 6 of 16 RA SFs (p > 0.05). IL4 was present at low concentrations in 4 of 22 PsA SFs (0.41 (0.8) pg/ml), and in 15 of 20 RA SFs (0.63 (0.09) pg/ml; p < 0.01). IL10 was found in 4 of 27 PsA SFs (12.3 (0.9) pg/ml) and in 27 of 32 RA SFs (37.3 (4.9) pg/ml; p < 0.0001). In all OA SFs cytokine concentrations were below the limit of detection.
CONCLUSION: The pattern of T cell derived cytokines in PsA SFs was similar to that of RA SFs. However, both the frequency and the concentrations of cytokines were lower in PsA SFs than in RA SFs, while OA SFs generally lacked any detectable T cell cytokines altogether. The presence of Th1 and Th2 cell derived cytokines in PsA SFs suggests the presence of activated T cells in the inflamed joint tissues and their participation in the immunoinflammatory events.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9924213      PMCID: PMC1752505          DOI: 10.1136/ard.57.11.691

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

1.  The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year.

Authors:  A Kavanaugh; C E Antoni; D Gladman; S Wassenberg; B Zhou; A Beutler; G Keenan; G Burmester; D E Furst; M H Weisman; J R Kalden; J Smolen; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2006-01-26       Impact factor: 19.103

Review 2.  T-cell studies in the spondyloarthropathies.

Authors:  E Märker-Hermann; P Schwab
Journal:  Curr Rheumatol Rep       Date:  2000-08       Impact factor: 4.592

Review 3.  Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors.

Authors:  P J Mease
Journal:  Ann Rheum Dis       Date:  2002-04       Impact factor: 19.103

4.  Cytokine blockers in psoriatic arthritis.

Authors:  P J Mease
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 5.  Tumor necrosis factor-alpha in psoriasis and psoriatic arthritis: a clinical, genetic, and histopathologic perspective.

Authors:  David Kane; Oliver FitzGerald
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

6.  Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets.

Authors:  Bertalan Mesko; Szilard Poliska; Andrea Szegedi; Zoltan Szekanecz; Karoly Palatka; Maria Papp; Laszlo Nagy
Journal:  BMC Med Genomics       Date:  2010-05-05       Impact factor: 3.063

Review 7.  T cells in psoriatic arthritis.

Authors:  Ernest Choy
Journal:  Curr Rheumatol Rep       Date:  2007-12       Impact factor: 4.592

8.  Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis.

Authors:  Christopher T Ritchlin; Sally A Haas-Smith; Ping Li; David G Hicks; Edward M Schwarz
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

9.  Exercise increases interleukin-10 levels both intraarticularly and peri-synovially in patients with knee osteoarthritis: a randomized controlled trial.

Authors:  Ida C Helmark; Ulla R Mikkelsen; Jens Børglum; Anders Rothe; Marie C H Petersen; Ove Andersen; Henning Langberg; Michael Kjaer
Journal:  Arthritis Res Ther       Date:  2010-07-01       Impact factor: 5.156

10.  Angiogenic and inflammatory properties of psoriatic arthritis.

Authors:  Toshiyuki Yamamoto
Journal:  ISRN Dermatol       Date:  2013-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.